Bioorganic and Medicinal Chemistry Letters, volume 25, issue 2, pages 404-409

Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors

Ivanenkov Yan 1, 2
Vasilevski Sergei V 1
Kukushkin Maksim E 1
Machulkin Alexey E. 1, 4
Veselov Mark S. 5
Chufarova Nina V 2, 6
Chernyaginab Elizaveta S 5
Vanzcool Anton S 7
Zyk Nikolay V. 1
Khutornenko Anastasia A. 8
Rusanov Alexander L. 9
Tonevitsky Alexander 10, 11
Dontsova Olga A. 1, 8
Publication typeJournal Article
Publication date2015-01-01
Quartile SCImago
Q2
Quartile WOS
Q2
Impact factor2.7
ISSN0960894X, 14643405
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Abstract
Regioselective synthesis, biological evaluation and 3D-molecular modeling for a series of novel diastereomeric 2-thioxo-5H-dispiro[imidazolidine-4,3-pyrrolidine-2,3-indole]-2,5(1H)-diones are described. The studied compounds have been tentatively identified as potent small molecule MDM2/p53 PPI inhibitors and can therefore be reasonably regarded as promising anticancer therapeutics.

Citations by journals

1
2
3
RSC Advances
RSC Advances, 3, 6.52%
RSC Advances
3 publications, 6.52%
Mendeleev Communications
Mendeleev Communications, 3, 6.52%
Mendeleev Communications
3 publications, 6.52%
Molecules
Molecules, 3, 6.52%
Molecules
3 publications, 6.52%
Chemistry of Heterocyclic Compounds
Chemistry of Heterocyclic Compounds, 3, 6.52%
Chemistry of Heterocyclic Compounds
3 publications, 6.52%
Russian Chemical Bulletin
Russian Chemical Bulletin, 3, 6.52%
Russian Chemical Bulletin
3 publications, 6.52%
Russian Journal of Organic Chemistry
Russian Journal of Organic Chemistry, 2, 4.35%
Russian Journal of Organic Chemistry
2 publications, 4.35%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2, 4.35%
International Journal of Molecular Sciences
2 publications, 4.35%
ChemistrySelect
ChemistrySelect, 2, 4.35%
ChemistrySelect
2 publications, 4.35%
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 2, 4.35%
European Journal of Medicinal Chemistry
2 publications, 4.35%
ChemMedChem
ChemMedChem, 2, 4.35%
ChemMedChem
2 publications, 4.35%
Phosphorus, Sulfur and Silicon and the Related Elements
Phosphorus, Sulfur and Silicon and the Related Elements, 1, 2.17%
Phosphorus, Sulfur and Silicon and the Related Elements
1 publication, 2.17%
Beilstein Journal of Organic Chemistry
Beilstein Journal of Organic Chemistry, 1, 2.17%
Beilstein Journal of Organic Chemistry
1 publication, 2.17%
Journal of Organic Chemistry
Journal of Organic Chemistry, 1, 2.17%
Journal of Organic Chemistry
1 publication, 2.17%
ACS Omega
ACS Omega, 1, 2.17%
ACS Omega
1 publication, 2.17%
Royal Society Open Science
Royal Society Open Science, 1, 2.17%
Royal Society Open Science
1 publication, 2.17%
Anti-Cancer Agents in Medicinal Chemistry
Anti-Cancer Agents in Medicinal Chemistry, 1, 2.17%
Anti-Cancer Agents in Medicinal Chemistry
1 publication, 2.17%
Pharmaceuticals
Pharmaceuticals, 1, 2.17%
Pharmaceuticals
1 publication, 2.17%
Biomolecules
Biomolecules, 1, 2.17%
Biomolecules
1 publication, 2.17%
Frontiers in Genetics
Frontiers in Genetics, 1, 2.17%
Frontiers in Genetics
1 publication, 2.17%
Tetrahedron
Tetrahedron, 1, 2.17%
Tetrahedron
1 publication, 2.17%
Chinese Chemical Letters
Chinese Chemical Letters, 1, 2.17%
Chinese Chemical Letters
1 publication, 2.17%
Medicinal Research Reviews
Medicinal Research Reviews, 1, 2.17%
Medicinal Research Reviews
1 publication, 2.17%
Advanced Synthesis and Catalysis
Advanced Synthesis and Catalysis, 1, 2.17%
Advanced Synthesis and Catalysis
1 publication, 2.17%
Journal of the American Chemical Society
Journal of the American Chemical Society, 1, 2.17%
Journal of the American Chemical Society
1 publication, 2.17%
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 1, 2.17%
Journal of Medicinal Chemistry
1 publication, 2.17%
Chemical Communications
Chemical Communications, 1, 2.17%
Chemical Communications
1 publication, 2.17%
Chemical Science
Chemical Science, 1, 2.17%
Chemical Science
1 publication, 2.17%
Synthesis
Synthesis, 1, 2.17%
Synthesis
1 publication, 2.17%
Molecular Diversity
Molecular Diversity, 1, 2.17%
Molecular Diversity
1 publication, 2.17%
1
2
3

Citations by publishers

1
2
3
4
5
6
7
Elsevier
Elsevier, 7, 15.22%
Elsevier
7 publications, 15.22%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 7, 15.22%
Multidisciplinary Digital Publishing Institute (MDPI)
7 publications, 15.22%
Springer Nature
Springer Nature, 7, 15.22%
Springer Nature
7 publications, 15.22%
Wiley
Wiley, 6, 13.04%
Wiley
6 publications, 13.04%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 5, 10.87%
Royal Society of Chemistry (RSC)
5 publications, 10.87%
American Chemical Society (ACS)
American Chemical Society (ACS), 4, 8.7%
American Chemical Society (ACS)
4 publications, 8.7%
Pleiades Publishing
Pleiades Publishing, 2, 4.35%
Pleiades Publishing
2 publications, 4.35%
Taylor & Francis
Taylor & Francis, 1, 2.17%
Taylor & Francis
1 publication, 2.17%
Beilstein-Institut
Beilstein-Institut, 1, 2.17%
Beilstein-Institut
1 publication, 2.17%
The Royal Society
The Royal Society, 1, 2.17%
The Royal Society
1 publication, 2.17%
Bentham Science
Bentham Science, 1, 2.17%
Bentham Science
1 publication, 2.17%
Frontiers Media S.A.
Frontiers Media S.A., 1, 2.17%
Frontiers Media S.A.
1 publication, 2.17%
Thieme
Thieme, 1, 2.17%
Thieme
1 publication, 2.17%
1
2
3
4
5
6
7
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Ivanenkov Y. et al. Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors // Bioorganic and Medicinal Chemistry Letters. 2015. Vol. 25. No. 2. pp. 404-409.
GOST all authors (up to 50) Copy
Ivanenkov Y., Vasilevski S. V., Beloglazkina E. K., Kukushkin M. E., Machulkin A. E., Veselov M. S., Chufarova N. V., Chernyaginab E. S., Vanzcool A. S., Zyk N. V., Skvortsov D., Khutornenko A. A., Rusanov A. L., Tonevitsky A., Dontsova O. A., Majouga A. G. Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors // Bioorganic and Medicinal Chemistry Letters. 2015. Vol. 25. No. 2. pp. 404-409.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.bmcl.2014.09.070
UR - https://doi.org/10.1016%2Fj.bmcl.2014.09.070
TI - Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors
T2 - Bioorganic and Medicinal Chemistry Letters
AU - Ivanenkov, Yan
AU - Vasilevski, Sergei V
AU - Kukushkin, Maksim E
AU - Machulkin, Alexey E.
AU - Veselov, Mark S.
AU - Chufarova, Nina V
AU - Chernyaginab, Elizaveta S
AU - Vanzcool, Anton S
AU - Zyk, Nikolay V.
AU - Khutornenko, Anastasia A.
AU - Rusanov, Alexander L.
AU - Dontsova, Olga A.
AU - Beloglazkina, Elena K.
AU - Skvortsov, Dmitry
AU - Tonevitsky, Alexander
AU - Majouga, Alexander G.
PY - 2015
DA - 2015/01/01 00:00:00
PB - Elsevier
SP - 404-409
IS - 2
VL - 25
SN - 0960-894X
SN - 1464-3405
ER -
BibTex |
Cite this
BibTex Copy
@article{2015_Ivanenkov,
author = {Yan Ivanenkov and Sergei V Vasilevski and Maksim E Kukushkin and Alexey E. Machulkin and Mark S. Veselov and Nina V Chufarova and Elizaveta S Chernyaginab and Anton S Vanzcool and Nikolay V. Zyk and Anastasia A. Khutornenko and Alexander L. Rusanov and Olga A. Dontsova and Elena K. Beloglazkina and Dmitry Skvortsov and Alexander Tonevitsky and Alexander G. Majouga},
title = {Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors},
journal = {Bioorganic and Medicinal Chemistry Letters},
year = {2015},
volume = {25},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016%2Fj.bmcl.2014.09.070},
number = {2},
pages = {404--409},
doi = {10.1016/j.bmcl.2014.09.070}
}
MLA
Cite this
MLA Copy
Ivanenkov, Yan, et al. ā€œDesign, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors.ā€ Bioorganic and Medicinal Chemistry Letters, vol. 25, no. 2, Jan. 2015, pp. 404-409. https://doi.org/10.1016%2Fj.bmcl.2014.09.070.
Found error?